Medtronic Cardiac Rhythm and Heart Failure
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medtronic Cardiac Rhythm and Heart Failure sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Medtronic Cardiac Rhythm and Heart Failure: 115 sponsored US clinical trials, 2 recruiting.
Medtronic Cardiac Rhythm and Heart Failure sponsors 115 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 100 completed. 6 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 10 trials.
Top-decile sponsor footprint
Medtronic Cardiac Rhythm and Heart Failure ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
100 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 3 of 3
MAVRIC VR ICD Registry
NCT00270933
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
NCT00267098
FAST (Fluid Accumulation Status Trial)
NCT00289276
TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics
NCT00279981
MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
NCT00305214
PREPARE - Primary Prevention Parameters Evaluation
NCT00279279
MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
NCT00305240
InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System
NCT00271232
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
NCT00643279
SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction
NCT00284830
InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy
NCT00289302
VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies
NCT00294034
Clinical Investigation of the SelectSecure Pacing Lead
NCT00266682
InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry
NCT00273182
The Atrial High Rate Episodes in Pacemaker Patients
NCT00627328
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Medtronic Cardiac Rhythm and Heart Failure pipeline
2 recruiting of 115 indexed (2% open); 100 completed (87%).
Phase mix: 6 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Heart Failure (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic Cardiac Rhythm and Heart Failure: open-pipeline peers nationwide
Peers matched on 115 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Medtronic Cardiac Rhythm and Heart Failure sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Eisai · 2% recruiting · 287 trials
- Bausch & Lomb Incorporated · 2% recruiting · 174 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
- Alcon Research · 2% recruiting · 275 trials
Related
What to do with this Medtronic Cardiac Rhythm and Heart Failure page
115 registered trials is a research-attention snapshot, not an endorsement of Medtronic Cardiac Rhythm and Heart Failure or any single study.
- 2 of Medtronic Cardiac Rhythm and Heart Failure's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Medtronic Cardiac Rhythm and Heart Failure studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medtronic Cardiac Rhythm and Heart Failure pipeline card: 115 registered trials from official public datasets.Report a data error.